Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Layla review
Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three screened clean against the full live FDA warning-letter index.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Layla at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not stated on the site
- Start
- Not published
How we scored Layla
Each factor is read off Layla's published pricing, disclosures and intake flow, and the six roll up into the 41/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Limited or state-gated availability — confirm yours first.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
The weakest showing on speed — a slow published timeline, or none at all.
Tiered or opaque — the true monthly is hard to pin down up front.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- joinlayla.com
Standing rates are $199 for semaglutide and $299 for tirzepatide, each discounted to $99 for a first month. The 08-17 note that it "starts at $1299" was not a monthly figure. A Cyber Week countdown was running in August, stopped at zero.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideInjectionRead live 2026-08-21 on /weight-loss: the monthly plan card reads "Starting at $99 / 1st Month (Originally $199 / month)". The STANDING rate is $199; $99 is a first-month promotion. CORRECTS the 08-17 screening sheet, which recorded "starts at $1299" — that is not the monthly rate. | $199 | InjectionRead live 2026-08-21 on /weight-loss: the monthly plan card reads "Starting at $99 / 1st Month (Originally $199 / month)". The STANDING rate is $199; $99 is a first-month promotion. CORRECTS the 08-17 screening sheet, which recorded "starts at $1299" — that is not the monthly rate. |
| Compounded tirzepatideInjectionRead live 2026-08-21: "Starting at $99 / 1st Month (Originally $299 / month)". Standing rate $299, first month $99. | $299 | InjectionRead live 2026-08-21: "Starting at $99 / 1st Month (Originally $299 / month)". Standing rate $299, first month $99. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Layla's public disclosures at last review and change often; confirm the current number on Layla's own site.
What we like
- Standing monthly rates are published on the plan cards rather than only the promotional first month
- Names three operating entities including its prescribing practices, Beluga Health, P.A. and Pennsylvania Medical, P.C.
- All three entities screened clean against the full live FDA warning-letter index
The caveats
- A "Cyber Week" banner and a "50% off, ends in" countdown reading 00:00:00 were running in August — manufactured urgency
- Quarterly plans are labeled per-month at $297 and $449, which cannot be reconciled with the cheaper monthly plans from the public page
- The headline everywhere is the $99 first month, not the $199 and $299 you actually pay from month two
- No state list published
Layla for working moms: our verdict
Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three screened clean against the full live FDA warning-letter index. It runs about $199/month.
We weigh Layla the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Layla will cost you
- Compounded semaglutide — Injection: $199/mo
- Compounded tirzepatide — Injection: $299/mo
That's roughly in line with the ~$179/month median across our roster.
The medications Layla prescribes
Layla prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Layla fits — and where it doesn't — for working moms
Right for you if…
- you want a straightforward semaglutide and tirzepatide program and will confirm the details before you commit.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Layla is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Someone who can read past the countdown to the standing rate and wants a named prescribing practice behind the prescription.
Alternatives to Layla
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Layla
Head-to-head & alternatives
Layla, answered
- How much does Layla cost?
- Budget around $199 a month — that was Layla's lowest ongoing compounded rate at last review ($199/mo semaglutide, $299/mo tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Layla without a scheduled video visit?
- Layla involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Layla offer both semaglutide and tirzepatide?
- Yes — Layla offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Layla rank for working moms?
- Layla earns 41/100 on our Rx-Readiness Score, ranking #289. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect Layla's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.